Terremoto Biosciences
PrivateLast Round
Series C
Apr 15, 2026
Total Funding Raised
$358M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Terremoto Biosciences is a biotechnology company that develops a drug discovery and development platform for highly targeted, small-molecule medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Terremoto Biosciences Comparables
Compare Terremoto Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alterome Therapeutics | 93% | |
| Atavistik | 84% | |
| Treeline Biosciences | 82% |
Terremoto Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 15, 2026 | ||||
| Series B | Nov 2, 2023 | ||||
| Series A | May 25, 2022 |
Key People
Founding team and executive leadership
Terremoto Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series B |
| RA Capital Management | Series C |
| Cormorant Asset Management | Series C, Series B |
| Deep Track Capital | Series C |
| Osage University Partners | Series C |
| OrbiMed | Series C, Series B, Series A |
| Cormorant Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 55% MoM, from 3.2K to 5K.
- Apr 15, 2026
$108M round completed.
Terremoto Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Terremoto Biosciences's valuation, stock price, and market status.
Is Terremoto a public or private company?
Terremoto is a private company.
What is the current stock price of Terremoto?
Terremoto is a private company with no public stock price. No recent secondary market data is available.
How much is Terremoto worth (valuation)?
Valuation information for Terremoto is not publicly available.
Can I buy Terremoto stock?
Terremoto shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Terremoto's last funding round?
Terremoto's most recent funding round was Series C on April 15, 2026.
Who are the main investors in Terremoto?
Key investors in Terremoto include EcoR1 Capital, OrbiMed, Novo Holdings, Third Rock Ventures.
Will Terremoto IPO soon?
No public IPO plans have been announced for Terremoto.
How can I track Terremoto secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Terremoto's secondary market activity and sign up for updates.